Genmab A/S
CSE:GMAB

Watchlist Manager
Genmab A/S Logo
Genmab A/S
CSE:GMAB
Watchlist
Price: 1 483.5 DKK 2.49% Market Closed
Market Cap: 97.7B DKK
Have any thoughts about
Genmab A/S?
Write Note

Wall Street
Price Targets

GMAB Price Targets Summary
Genmab A/S

Wall Street analysts forecast GMAB stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for GMAB is 2 523.15 DKK with a low forecast of 348.59 DKK and a high forecast of 5 145 DKK.

Lowest
Price Target
348.59 DKK
77% Downside
Average
Price Target
2 523.15 DKK
70% Upside
Highest
Price Target
5 145 DKK
247% Upside
Genmab A/S Competitors:
Price Targets
IGMS
IGM Biosciences Inc
125% Upside
BLAU3
Blau Farmaceutica SA
23% Upside
SVE
Synthaverse SA
52% Upside
6955
Shandong Boan Biotechnology Co Ltd
43% Upside
SWTX
SpringWorks Therapeutics Inc
77% Upside
MYGN
Myriad Genetics Inc
57% Upside
CSL
CSL Ltd
17% Upside
RXRX
Recursion Pharmaceuticals Inc
76% Upside

Revenue
Forecast

Revenue Estimate
Genmab A/S

For the last 8 years the compound annual growth rate for Genmab A/S's revenue is 40%. The projected CAGR for the next 3 years is 20%.

40%
Past Growth
20%
Estimated Growth
Estimates Accuracy
1%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Genmab A/S

For the last 8 years the compound annual growth rate for Genmab A/S's operating income is 28%. The projected CAGR for the next 3 years is 24%.

28%
Past Growth
24%
Estimated Growth
Estimates Accuracy
4%
Average Beat

Net Income
Forecast

Net Income Estimate
Genmab A/S

For the last 8 years the compound annual growth rate for Genmab A/S's net income is 24%. The projected CAGR for the next 3 years is 22%.

24%
Past Growth
22%
Estimated Growth
Estimates Accuracy
1%
Average Beat

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is GMAB's stock price target?
Price Target
2 523.15 DKK

According to Wall Street analysts, the average 1-year price target for GMAB is 2 523.15 DKK with a low forecast of 348.59 DKK and a high forecast of 5 145 DKK.

What is Genmab A/S's Revenue forecast?
Projected CAGR
20%

For the last 8 years the compound annual growth rate for Genmab A/S's revenue is 40%. The projected CAGR for the next 3 years is 20%.

What is Genmab A/S's Operating Income forecast?
Projected CAGR
24%

For the last 8 years the compound annual growth rate for Genmab A/S's operating income is 28%. The projected CAGR for the next 3 years is 24%.

What is Genmab A/S's Net Income forecast?
Projected CAGR
22%

For the last 8 years the compound annual growth rate for Genmab A/S's net income is 24%. The projected CAGR for the next 3 years is 22%.

Back to Top